Introduction
============

Cytochrome P450s (CYPs; EC 1.14.x.x) are important membrane-bound enzymes that metabolize a number of endogenous and exogenous substrates. Human CYP is a superfamily of enzymes that are divided into 18 families with a total of 57 isoforms (Lewis [@b9]). The *CYP3A4* gene is located on chromosome 7q22.1 and is the main CYP isoform responsible for the metabolism of more than 50% of clinically used drugs (Williams et al. [@b19]). As CYPs are called as phase I drug-metabolizing enzymes, there is also a group of phase II drug-metabolizing enzymes that catalyze the conjugation of their substrates. UDP-Glucuronosyltransferases (UGTs; EC 2.4.1.17), which are the major phase II drug-metabolizing enzymes, metabolize drugs by transferring the glucuronic acid moiety of UDP-glucuronic acid to the substrates (Dutton [@b3]; Mackenzie et al. [@b10]).

While the active site of CYPs locates in the cytoplasmic side of endoplasmic reticulum (ER), the active site of UGT proteins locates in the luminal side of ER (Shepherd et al. [@b14]). Whereas it has been reported that CYPs and UGTs functionally interact with each other, as CYPs catalyze hydroxylation of substrates so that UGT can transfer glucuronic acid to the hydroxyl group of the substrates (Nakajima and Yokoi [@b12]; Zheng et al. [@b20]). Physical interactions between CYPs and UGTs have been demonstrated by immunoprecipitation assays utilizing anti-CYP3A4 and anti-UGT2B7 antibodies (Fremont et al. [@b4]; Ishii et al. [@b6]; Takeda et al. [@b17]), supporting that CYPs and UGTs are interacting with each other to cooperatively metabolize the substrates. Not only UGTs but also other drug-metabolizing enzymes, such as epoxide hydrolase 1, have been reported to interact with CYPs (Taura et al. [@b18]). However, the physiological role of these protein interactions is still largely unknown.

Metabolosome, which is a functional unit of metabolism, is the multimolecular assembly composed of metabolizing enzymes, transport-related proteins (transporters, channels or pumps), regulatory proteins, scaffold proteins, and other functional cellular components, which are assembled by means of multiple protein--protein interactions and/or protein--lipid interactions (Mori et al. [@b11]). The fact that human CYPs have been reported to interact with other proteins such as UGTs and epoxide hydrolase led us to investigate whether CYPs form a metabolosome assembled by extensive protein--protein interactions. In this study, large-scale analysis of protein--protein interaction involving CYP3A4 was carried out by shotgun liquid chromatography--mass spectrometry (LC-MS/MS) proteomic analysis of immunoprecipitated proteins to identify proteins interacting with human CYP3A4 in human liver microsomes.

Materials and Methods
=====================

Chemicals and reagents
----------------------

Human liver microsomes were obtained from BD Gentest (Woburn, MA). Rabbit anti-human CYP3A4 antibody (H00001576-D01) was purchased from Abnova (Taipei, Taiwan). Control antibodies (IgG from rabbit serum) were purchased from Sigma--Aldrich (St Louis, MO) and Abcam (Cambridge, MA). Immunoprecipitation Kit Dynabeads ProteinG was purchased from Invitrogen (Carlsbad, CA). All other chemicals and solvents were of analytical grade or the highest grade commercially available.

Immunoprecipitation and Nano-LC-MS/MS analysis of the immunoprecipitate
-----------------------------------------------------------------------

Immunoprecipitation assay and nano-LC-MS/MS analysis were conducted as described before (Fujiwara and Itoh [@b5]).

Results
=======

Identification of proteins immunoprecipitated with human CYP3A4 antibody
------------------------------------------------------------------------

CYP3A4 is one of the major CYP isoforms involved in metabolism of a wide variety of drugs in the human liver. To identify proteins that interact with CYP3A4, human liver microsomes were subjected to an immunoprecipitation assay with rabbit anti-human CYP3A4 antibody, followed by a shotgun analysis of the immunoprecipitate by an LC-MC/MC analysis. Our shotgun analysis revealed that 149 proteins including human CYP3A4 were coimmunoprecipitated with anti-human CYP3A4 antibody (Fig. [1](#fig01){ref-type="fig"}). Human CYP3A4 has been reported to interact with human UGTs and epoxide hydrolases. In this study, peptide sequences of these proteins were observed in the LC-MC/MC analysis of the immunoprecipitate, showing the reproducibility of the previous findings. Several peptide sequences of other proteins such as protein transport protein Sec61 were also obtained in the shotgun analysis. These data indicate that CYP3A4 might interact with multiple proteins to form a metabolosome.

![Peptide sequence analysis of human CYP3A4. Six peptide sequences of human CYP3A4 were obtained with the shotgun analysis of the immunoprecipitate with anti-CYP3A4 antibody (A). The middle panel indicates the MS/MS spectra of the peptide (B), whereas the bottom panel indicates ion tables (C).](prp20002-e00053-f1){#fig01}

To exclude the possibility that the anti-CYP3A4 antibody used in the immunoprecipitation assay nonspecifically reacted to proteins in human liver microsomes, we incorporated our previous data into the current study. We have previously carried out immunoprecipitation assays with two different control rabbit IgG, followed by shotgun analysis (Fujiwara and Itoh [@b5]). It was revealed that more than 100 proteins were nonspecifically interacted with IgG in the human liver microsomes. [Table S1](#SD1){ref-type="supplementary-material"} shows the list of proteins specifically coimmunoprecipitated with the anti-human CYP3A4 antibody.

While the list of proteins coimmunoprecipitated with the anti-CYP3A4 antibody contains several mitochondrial, outer membrane, and extracellular proteins, it also contains a number of proteins that are present in the ER such as CYP3A5, CYP2A6, CYP4F2, and bile acyl-CoA synthetase (Table [1](#tbl1){ref-type="table"}).

###### 

ER Proteins that were coimmunoprecipitated with anti-CYP3A4 antibody

  No.   Accession     Score   Mass     Number of peptide sequences   emPAI   Protein name
  ----- ------------- ------- -------- ----------------------------- ------- -----------------------------------------------------------------
  2     CP3A4_HUMAN   140     57705    6                             0.21    Cytochrome P450 3A4
  7     S61A1_HUMAN   87      52687    1                             0.07    Protein transport protein Sec61 subunit alpha isoform 1
  9     SSRG_HUMAN    73      21067    1                             0.18    Translocon-associated protein subunit gamma
  10    NDUB4_HUMAN   70      15256    1                             0.26    NADH dehydrogenase \[ubiquinone\] 1 beta subcomplex subunit 4
  12    ERP29_HUMAN   64      29032    1                             0.13    Endoplasmic reticulum resident protein 29
  14    S27A5_HUMAN   61      76420    2                             0.1     Bile acyl-CoA synthetase
  15    CO4A_HUMAN    61      194247   1                             0.02    Complement C4-A
  16    CISD2_HUMAN   59      15497    2                             0.56    CDGSH iron-sulfur domain-containing protein 2
  18    AT2A3_HUMAN   52      115444   1                             0.03    Sarcoplasmic/endoplasmic reticulum calcium ATPase 3
  21    SSRD_HUMAN    50      19158    1                             0.2     Translocon-associated protein subunit delta
  22    NDUAC_HUMAN   49      17104    1                             0.23    NADH dehydrogenase \[ubiquinone\] 1 alpha subcomplex subunit 12
  23    FAS_HUMAN     48      275877   1                             0.01    Fatty acid synthase
  24    AT1A1_HUMAN   48      114135   1                             0.03    Sodium/potassium-transporting ATPase subunit alpha-1
  27    GLU2B_HUMAN   43      60357    1                             0.06    Glucosidase 2 subunit beta
  28    GANAB_HUMAN   43      107263   1                             0.03    Neutral alpha-glucosidase AB
  36    CP3A5_HUMAN   26      57357    1                             0.06    Cytochrome P450 3A5
  38    TM109_HUMAN   25      26194    1                             0.15    Transmembrane protein 109
  39    CP4F2_HUMAN   23      60442    1                             0.06    Leukotriene-B(4) omega-hydroxylase 1
  41    CP2A6_HUMAN   22      56636    1                             0.07    Cytochrome P450 2A6
  47    STRUM_HUMAN   18      135113   1                             0.03    WASH complex subunit strumpellin

Discussion and Conclusions
==========================

CYPs are the predominant proteins that are involved in metabolism of a wide variety of drugs. Due to a greater interest especially in the biomedical field, the insight into the molecular mechanism of CYPs-catalyzed metabolism (i.e., hydroxylation) of the substrate has been thoroughly investigated. Protein--protein interaction is known as a crucial factor that regulates the function of the proteins. CYPs have been reported to interact with a microsomal protein, NADPH-cytochrome P450 reductase (CPR). Indeed, these interactions are required for CYP catalysis (Bernhardt [@b1]). The physical and functional interactions between CYP and CPR have been widely demonstrated. Recent studies also revealed that CYPs interact with other drug-metabolizing enzymes expressed in ER such as UGTs and epoxide hydrolase (Taura et al. [@b18]; Ishii et al. [@b6]). It was further demonstrated that the protein--protein interaction between CYPs and UGTs affected their enzymatic activities (Ishii et al. [@b7]). Not only with other proteins, but CYPs also interact with CYP enzymes themselves to form homo- and heterodimers (Subramanian et al. [@b15], [@b16]; Davydov [@b2]; Reed and Backes [@b13]). The presence of these complexities of the protein--protein interaction in ER suggests that CYP3A4 might be involved in the formation of a metabolosome, a functional unit of metabolism consisting of multiple metabolism-related proteins.

Most of the metabolites of endogenous and exogenous compounds produced by CYPs are subsequently metabolized by phase II drug-metabolizing enzymes such as UGTs to further increase in their hydrophilicity. The fact that the majority of CYPs are localized on the cytoplasmic and UGTs on the luminal side of the ER membrane leads us to believe that their substrates and metabolites need to be efficiently translocated across the ER membrane. However, CYPs and UGTs solely possess a transmembrane helix, which make it impossible to form a pore, suggesting that other proteins might be involved in the transport of the hydrophilic substrates/metabolites across the ER membrane. In this study, it was revealed that a number of microsomal proteins were interacting with CYP3A4 in the microsomal fraction (Table [1](#tbl1){ref-type="table"}). While the functional relationship between CYP3A4 and the interacting proteins is largely unknown, the formation of a metabolosome might contribute to the accelerated translocation of the hydrophilic substrates/metabolites across the ER membrane. This hypothesis is supported by the finding that several translocators such as Sec61 and translocon-associated proteins were coimmunoprecipitated with CYP3A4 in this study (Table [1](#tbl1){ref-type="table"}). While the primary role of the translocators is to translocate polypeptides across the ER membrane, it has been reported that Sec61 was also involved in efflux of a small molecule, calcium, from the ER (Lang et al. [@b8]). The functional relationship between CYP3A4 and proteins listed in Table [1](#tbl1){ref-type="table"} needs to be further investigated in the future.

To exclude the proteins nonspecifically interacting with the antibody used in this study, we incorporated our previous data (Fujiwara and Itoh [@b5]), which showed that more than 100 proteins were nonspecifically interacted with IgG in the human liver microsomes. However, many mitochondrial, outer membrane, and extracellular proteins such as ATP synthase and transhydrogenase were still included in the list of proteins that were found to interact with CYP3A4 (Table S1). While it is possible that those proteins are transiently present in the ER to interact with CYP3A4, it could be a result of indirect/nonspecific interactions.

In conclusion, we performed a shotgun analysis of immunoprecipitate obtained with anti-CYP3A4 antibody by utilizing nano-LC-MS/MS analysis. Twenty ER proteins were newly identified as proteins interacting with CYP3A4 in human liver microsomes. These proteins might be associated with a formation of a metabolosome involving CTP3A4. Functional roles of newly identified proteins interacting with CYP3A4 in metabolism and translocation of substrates or metabolites need to be examined in future studies.
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**Table S1.** Proteins that were coimmunoprecipitated with anti-CYP3A4 antibody. Proteins specifically immunoprecipitated with the anti-CYP3A4 antibody are shown. Proteins expressed in the ER are highlighted with a red color.
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